PSYC continues to strengthen its leadership team with key brand and sales advisory board appointments

PSYC continues to strengthen its leadership team with key brand and sales advisory board appointments

LAKE OSWEGO, OR, January 10, 2022 (GLOBE NEWSWIRE) – Global Trac Solutions, Inc. (OTCPink: PSYC) (“Global” “PSYC” or the “Company”) a media leader for the emerging sector of psychedelics, the authorities behind Psychedelic Spotlight, a high-profile news and information platform, are pleased to announce that as the company continues to dedicate a significant focus Towards strengthening its core leadership team, it is proud to welcome Mitchell J. Schlesinger and Sarah Abelson to PSYC’s growing advisory board as additions to key sales and branding experts.

Combined with the recent additions of Christopher Betonte and Craig Schlesinger, the company believes it is effectively aligning the PSYC Advisory Board with passionate professionals who can contribute a wealth of knowledge and experience vital to the company and its growing team numbing the limelight across the areas of business operations, financial management, marketing, sales and branding.

With over 30 years of experience in creative advertising, strategic marketing and branding, which includes working with global brands including Avis Rent-A-Car, Norwegian Cruises, Costa Cruises and Marco Polo Cruises, the company will look to Mr. Schlesinger for direction and leadership. With strategic brand messaging, development and implementation of sales and marketing key performance indicators (“KPI’s”) for the Spotlight Psychedelic media platform as well as enhancing PSYC’s evolving image within the general market segment.

“My career has been spent building and innovating brands with unique product placements by designing strategic brand executive programs,” said Mr. Schlesinger. “The emerging psychedelic sector is particularly unique on many fronts and is the latest in revolutionary medical treatments. I look forward to working with the PSYC team to innovate and monetize and cement the company’s position as the industry’s dominant news, multimedia and business platform for both consumers and business partners. It’s an exciting time to join in. To the dynamic PSYC team.”

In the meantime, Ms. Abelson will transition into her role as a consultant to PSYC after having served as director of Psychedelic Spotlight since early 2021. She initially joined the Psychedelic Spotlight team in June 2020 as a sales and marketing consultant and has played an integral role in the past year and a half with the development of the brand’s visual aesthetic Dynamic and industry leading which is now associated with Psychedelic Spotlight.

“It is an honor for me to be on the PSYC Advisory Board,” said Ms. Abelson. “I am excited to continue lending my vision and support to the team and to help influence the growth of our ever-growing audience for Psychedelic Spotlight. I believe there is so much in store for this talented team, and I am humbled by the opportunity to become a consultant, and excited about what is to come.”

“Surrounding the Spotlight anesthetic team and I with highly skilled individuals who are inspiring and passionate about what we are building here at PSYC provides us, I believe, a very unique competitive advantage in terms of our ability to continue to implement on our core initiatives focused on Growth and monetization through 2022 and beyond.” “In my opinion, an important part of our current monetization initiatives is directly related to our ability to develop and deploy effective sales, marketing and branding initiatives. For this reason, I am confident that the additions of Mr. Schlesinger and Mrs. Abelson to the PSYC Advisory Board will prove extremely beneficial to PSYC based on the dynamic experience, knowledge, and passion that they will each be able to contribute at this pivotal time in our company’s growth.”

About Global Trac Solutions, Inc. (OTCPink: PSYC)

At Global Trac Solutions, we combine media, creativity, and technology to develop and disseminate thought-provoking ideas and solutions that advance and transform approaches to some of society’s most pressing matters.

PSYC has expressed its intent and commitment to position itself at the forefront of the drug revolution and as a resource center for discovering and understanding the latest research and business opportunities related to drug-inspired drugs. In conjunction with the FDA’s more open approach to psychedelics, and with several major US cities continuing to agree to decriminalize psilocybin, we think investors are speculating that the psychedelic boom could be even greater than that of cannabis. PSYC is your source for current psychedelic investment related news and the latest research improving public health, moving this sector into the mainstream.

We are committed to a forward-thinking approach that embraces pioneering new technology and innovations and with a business development vision, we intend to continue to evolve in these unrestricted areas as future industry leaders.

Disclaimer of forward-looking statements:

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Exchange Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. In some cases, you may define forward-looking statements by the following words: “expect,” “believe,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “continued,” “plan,” or “Possible,” “expect,” “project,” “should,” “will,” “will,” or the negativity of these or other similar terms, although not all forward-looking statements contain such words. Forward-looking statements are not a guarantee for future performance or results and will not necessarily be accurate indicators of when, or during which such performance or results will be achieved.Forward-looking statements are based on information available at the time the statements were made and include known and unknown risks, uncertainty and other factors, including the impact of COVID-19 The success of the current vaccine distribution, and the adverse effect of Omicron being variable, may cause our results, levels of activity, performance, or achievements to differ materially from the information contained or included in the forward-looking statements in this press release.This press release should be considered in light of all company filings that have been disclosed. reported on the OTC website and not incorporated with reference to such reports.

Disclaimer: Global Trac Solutions, Inc. In no way condone or condone the use, purchase, sale or transmission of any illegal materials, nor do we encourage or condone any illegal activities. We support a harm reduction approach for the purpose of education and the promotion of individual and public safety. If you choose to use narcotic substances, please do so responsibly.

Company contact:
Global Track Solutions, Inc. (PSYC)
(702) 239-1919

Leave a Comment

Your email address will not be published. Required fields are marked *